OCX - OncoCyte Corp - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

OCX is currently covered by 5 analysts with an average price target of $15.55. This is a potential upside of $13.09 (532.11%) from yesterday's end of day stock price of $2.46.

OncoCyte Corp's activity chart (see below) currently has 23 price targets and 34 ratings on display. The stock rating distribution of OCX is 72.73% BUY and 27.27% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.52% with an average time for these price targets to be met of 58.45 days.

Highest price target for OCX is $5, Lowest price target is $3, average price target is $15.55.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 24-Apr-2024. First documented stock forecast 24-Mar-2016.

Currently out of the existing stock ratings of OCX, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4.25

$1.79 (72.76%)

3.6

2 days ago

2/4 (50%)

$1.79 (72.76%)

58

Buy

5

$2.54 (103.25%)

5

11 days ago

0/4 (0%)

$2.47 (97.63%)

Hold

3

$0.54 (21.95%)

3.5

5 months 13 days ago

2/5 (40%)

$0.24 (8.70%)

2

Hold

10

$7.54 (306.50%)

80

1 years 4 months 25 days ago

1/4 (25%)

$0.5 (5.26%)

204

Buy

25

$22.54 (916.26%)

62

1 years 11 months 2 days ago

1/2 (50%)

$5.31 (26.97%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCX (OncoCyte Corp) average time for price targets to be met?

On average it took 58.45 days on average for the stock forecasts to be realized with a an average price target met ratio 41.52

Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?

PAUL KNIGHT

Which analyst has the most public recommendations on OCX (OncoCyte Corp)?

Paul Knight works at KEYBANK and has 7 price targets and 4 ratings on OCX

Which analyst is the currently most bullish on OCX (OncoCyte Corp)?

Steven Mah with highest potential upside - $137.54

Which analyst is the currently most reserved on OCX (OncoCyte Corp)?

Keay Nakae with lowest potential downside - -$1.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?